Skip to main content
Year archive

GL Pharm Tech Corp. — 2019 filings

All 36 regulatory filings released by GL Pharm Tech Corp. (204840) in 2019, sourced directly from the official regulator.

36 Filings
2019 Period
2019 filings (36)
Filing Released Lang
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2019-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-13 Korean
유상증자1차발행가액결정
Share Issue/Capital Change
2019-12-04 Korean
권리락(유상증자)
Share Issue/Capital Change
2019-12-04 Korean
투자설명서
Capital/Financing Update
2019-11-29 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-10-11 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2019-10-01 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2019-10-01 Korean
증권신고서(지분증권)
Capital/Financing Update
2019-10-01 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-09-23 Korean
전환가액의조정
Capital/Financing Update
2019-09-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2019-09-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2019-09-04 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-08-19 Korean
주주총회소집결의
AGM Information
2019-08-06 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-08-06 Korean
[기재정정]사업보고서 (2018.12)
Audit Report / Information FY 2018
2019-06-28 Korean
전환가액의조정(제4회차)
Capital/Financing Update
2019-06-14 Korean
전환가액의조정(제2회차)
Capital/Financing Update
2019-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-06-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-05-17 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-08 Korean
전환가액의조정(제3회차)
Capital/Financing Update
2019-04-17 Korean
사업보고서 (2018.12)
Audit Report / Information FY 2018
2019-03-29 Korean
기업설명회(IR)개최
Investor Presentation
2019-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-21 Korean
전환가액의조정(제4회차)
Capital/Financing Update
2019-03-14 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-13 Korean
주주총회소집공고
AGM Information
2019-03-06 Korean
주주총회소집결의
AGM Information
2019-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2019-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2019-03-04 Korean
전환가액의조정(제3회차)
Capital/Financing Update
2019-01-17 Korean
투자판단관련주요경영사항(신경병증성 통증치료제 프레가발린서방정(GLA5PR)식품의약품안전처 국내 품목허가 승인 완료)
Regulatory Filings
2019-01-14 Korean